SWHR logo
Society for Women's
Health Research

SWHRCelebrating 20 Years


Member Login | Contact Us


Home About Us Advocacy Education Research News Events Donate
Public Education

CFC #: 10484
Women's Health Research

Sign Up for E-News

SWHR on Twitter SWHRs Blog SWHR on Facebook
Follow us on Linkedin SWHR on YouTube
 

Inclusion of Women in Medical Research

More research is needed to understand women's unique health needs, and it is crucial that women who do participate in research studies are informed volunteers. SWHR's campaign, Some Things Only a Woman Can Do provides women with accurate information about volunteering for medical research.

Frequently Asked Questions about Medical Research

Milestones in the Inclusion of Women in Research 

  • 1977- The Food and Drug Administration (FDA) bars women of child bearing potential from participating in most early phase clinical research.
  • 1985- A United States Public Health Service task force concludes that exclusion of women from clinical research was detrimental to women's health.
  • 1986- The National Institutes of Health (NIH) adopts guidelines urging the inclusion of women in NIH-sponsored clinical research.
  • 1990- The Society for Women's Health Research is founded and asks the General Accounting Office (GAO) to examine whether NIH is following its 1986 guideline.
  • 1990- A GAO report reveals that the NIH guidelines are not being followed. The Physician's Health or "aspirin" study, designed to examine the impact of taking aspirin on cardiovascular disease, is one of many large studies not included women highlighted by the report.
  • 1993- The NIH Revitalization Act of 1993 mandates that the NIH must ensure that women and members of minorities and their subpopulations are included in all human subject research.
  • 1993- The FDA rescinds earlier guidelines barring the participation of women with child-bearing potential from most early phase research.
  • 2000- The GAO concludes that although women are now included in clinical research proportionate to their representation in the population, analysis by sex of subjects is rare.
  • 2001- The GAO concludes FDA not effectively monitoring research data to determine how sex differences affect drug safety and effectiveness.

HomeAbout UsAdvocacyEducationResearchPress RoomEventsPrivacy PolicySitemap

Society for Women's Health Research | 1025 Connecticut Ave., NW, Suite 701, Washington, DC 20036
Phone: (202)223-8224 | Fax: (202)833-3472 | E-mail: info@swhr.org
SWHR does not provide medical advice or give referrals to health care providers. The information provided on this
site is designed to support, not replace, the relationship that exists between you and your doctor.
This website does not accept advertisements.